{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:47:18Z","timestamp":1768535238902,"version":"3.49.0"},"reference-count":46,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"unspecified","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00017\/3"],"award-info":[{"award-number":["MC_UU_00017\/3"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00017\/5"],"award-info":[{"award-number":["MC_UU_00017\/5"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/05\/013\/18296"],"award-info":[{"award-number":["PG\/05\/013\/18296"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["SP\/03\/002"],"award-info":[{"award-number":["SP\/03\/002"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["SP\/08\/010\/25939"],"award-info":[{"award-number":["SP\/08\/010\/25939"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["SP\/14\/3\/31114"],"award-info":[{"award-number":["SP\/14\/3\/31114"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011718","name":"Macular Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011718","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Abbott Products Operations AG"},{"name":"Bayer Healthcare AG"},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,1,10]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Aspirin and omega-3 fatty acids (FAs) are potential disease modifiers of age-related macular degeneration (AMD), but previous studies have produced inconsistent findings. Randomised evidence for the efficacy and safety of aspirin and omega-3 FAs on AMD is presented in this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>ASCEND-Eye is a substudy of eye effects in the 2\u00d72 factorial design ASCEND (A Study of Cardiovascular Events iN Diabetes) double-blind, randomised, placebo-controlled trial for the primary prevention of cardiovascular events. Reports of AMD diagnoses were sourced from 6\u2009monthly ASCEND follow-up questionnaires and a Visual Function Questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>15\u2009480 UK adults at least 40 years of age with diabetes but no evident cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>100\u2009mg aspirin daily versus placebo and, separately, 1\u2009g omega-3 FAs daily versus placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measure<\/jats:title>\n                    <jats:p>The first post-randomisation reports of AMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During 7.4 years of follow-up, 122 (1.6%) participants randomised to aspirin were reported as having AMD, compared with 138 (1.8%) randomised to placebo (rate ratio 0.88; 95%\u2009CI 0.69 to 1.12; p=0.31). AMD occurred in 130 (1.7%) participants randomised to omega-3 FAs, compared with 130 (1.7%) randomised to placebo (rate ratio 0.99; 95%\u2009CI 0.78 to 1.27; p=0.99).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>No clinically-meaningful effects of aspirin or omega-3 FAs on AMD were found. Although the study had very limited statistical power to detect clinically relevant effects, these data overcome some methodological limitations of previous observational studies, providing randomised evidence of both treatments on AMD, which could contribute to future meta-analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN60635500\">ISRCTN60635500<\/jats:ext-link>\n                      and\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00135226\">NCT00135226<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-090605","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T12:53:21Z","timestamp":1740574401000},"page":"e090605","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"isrctn60635500","registry":"10.18810\/isrctn"},{"clinical-trial-number":"nct00135226","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8647-0366","authenticated-orcid":false,"given":"Emily","family":"Sammons","sequence":"first","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Bowman","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Stevens","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Buck","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Hammami","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Parish","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Armitage","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"2025121403334980000_15.2.e090605.1","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"Steinmetz","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2025121403334980000_15.2.e090605.2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jamainternmed.2013.1583","article-title":"The association of aspirin use with age-related macular degeneration","volume":"173","author":"Liew","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2025121403334980000_15.2.e090605.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.65406"},{"key":"2025121403334980000_15.2.e090605.4","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.8.1143"},{"key":"2025121403334980000_15.2.e090605.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.05.031"},{"key":"2025121403334980000_15.2.e090605.6","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.76"},{"key":"2025121403334980000_15.2.e090605.7","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/IAE.0000000000003465","article-title":"ASSOCIATION OF PLASMA \u03c9-3 FATTY ACIDS WITH EARLY AGE-RELATED MACULAR DEGENERATION IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS","volume":"42","author":"Karger","year":"2022","journal-title":"Retina (Philadelphia, Pa)"},{"key":"2025121403334980000_15.2.e090605.8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ophtha.2020.08.018","article-title":"Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2","volume":"128","author":"Agr\u00f3n","year":"2021","journal-title":"Ophthalmology"},{"key":"2025121403334980000_15.2.e090605.9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ophtha.2016.12.033","article-title":"Dietary Intakes of Eicosapentaenoic Acid and Docosahexaenoic Acid and Risk of Age-Related Macular Degeneration","volume":"124","author":"Wu","year":"2017","journal-title":"Ophthalmology"},{"key":"2025121403334980000_15.2.e090605.10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ajcn\/73.2.209","article-title":"Prospective study of dietary fat and the risk of age-related macular degeneration","volume":"73","author":"Cho","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"2025121403334980000_15.2.e090605.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.4997"},{"key":"2025121403334980000_15.2.e090605.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.01.005"},{"key":"2025121403334980000_15.2.e090605.13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/jamaophthalmol.2020.4409","article-title":"Effect of Vitamin D and \u03c9-3 Fatty Acid Supplementation on Risk of Age-Related Macular Degeneration: An Ancillary Study of the VITAL Randomized Clinical Trial","volume":"138","author":"Christen","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"2025121403334980000_15.2.e090605.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2003.11.069"},{"key":"2025121403334980000_15.2.e090605.15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ahj.2017.12.006","article-title":"ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes","volume":"198","author":"Bowman","year":"2018","journal-title":"Am Heart J"},{"key":"2025121403334980000_15.2.e090605.16","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(08)61759-6","article-title":"Age-related macular degeneration","volume":"372","author":"Coleman","year":"2008","journal-title":"The Lancet"},{"key":"2025121403334980000_15.2.e090605.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01565-8"},{"key":"2025121403334980000_15.2.e090605.18","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.117.9.1203"},{"key":"2025121403334980000_15.2.e090605.19","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2023.101184","article-title":"ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration","volume":"35","author":"Sammons","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"key":"2025121403334980000_15.2.e090605.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804988"},{"key":"2025121403334980000_15.2.e090605.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804989"},{"key":"2025121403334980000_15.2.e090605.22","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.7.1050"},{"key":"2025121403334980000_15.2.e090605.23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2024.01.018","article-title":"ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy","volume":"131","author":"Sammons","year":"2024","journal-title":"Ophthalmology"},{"key":"2025121403334980000_15.2.e090605.24","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.564"},{"key":"2025121403334980000_15.2.e090605.25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2307\/2529990","article-title":"A simple approximation for calculating sample sizes for comparing independent proportions","volume":"36","author":"Fleiss","year":"1980","journal-title":"Biometrics"},{"key":"2025121403334980000_15.2.e090605.26","doi-asserted-by":"crossref","unstructured":"Armitage P , Berry G , Matthews JNS . Statistical Methods in Medical Research. 4th edn. Blackwell Publishing, 2002.","DOI":"10.1002\/9780470773666"},{"key":"2025121403334980000_15.2.e090605.27","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"2025121403334980000_15.2.e090605.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-0620(85)80003-7"},{"key":"2025121403334980000_15.2.e090605.29","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1976.220"},{"key":"2025121403334980000_15.2.e090605.30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001571","article-title":"5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of \u03c9-3 polyunsaturated fatty acids","volume":"3","author":"Sapieha","year":"2011","journal-title":"Sci Transl Med"},{"key":"2025121403334980000_15.2.e090605.31","doi-asserted-by":"publisher","DOI":"10.1177\/001316446002000104"},{"key":"2025121403334980000_15.2.e090605.32","doi-asserted-by":"publisher","DOI":"10.1076\/opep.6.2.125.1558"},{"key":"2025121403334980000_15.2.e090605.33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14740338.2014.889680","article-title":"Does long-term aspirin use increase the risk of neovascular age-related macular degeneration?","volume":"13","author":"Christen","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"2025121403334980000_15.2.e090605.34","first-page":"687","article-title":"Aspirin and age-related macular degeneration: positives versus negatives","volume":"13","author":"Nowak","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"2025121403334980000_15.2.e090605.35","first-page":"691","article-title":"Does aspirin increase the risk of age-related macular degeneration?","volume":"13","author":"Chong","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"2025121403334980000_15.2.e090605.36","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.6.774"},{"key":"2025121403334980000_15.2.e090605.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01624-0"},{"key":"2025121403334980000_15.2.e090605.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803955"},{"key":"2025121403334980000_15.2.e090605.39","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1800722"},{"key":"2025121403334980000_15.2.e090605.40","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1805819"},{"key":"2025121403334980000_15.2.e090605.41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jamaophthalmol.2024.1584","article-title":"Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical Trial","volume":"142","author":"Robman","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"2025121403334980000_15.2.e090605.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.10.036"},{"key":"2025121403334980000_15.2.e090605.43","unstructured":"The Royal College of Ophthalmologists . National Ophthalmology Database Audit, Available: https:\/\/www.nodaudit.org.uk [Accessed 13 Mar 2023]."},{"key":"2025121403334980000_15.2.e090605.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2004.06.002"},{"key":"2025121403334980000_15.2.e090605.45","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.ophtha.2015.08.002","article-title":"The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study","volume":"122","author":"Joachim","year":"2015","journal-title":"Ophthalmology"},{"key":"2025121403334980000_15.2.e090605.46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/ajcn\/88.2.398","article-title":"Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration","volume":"88","author":"Augood","year":"2008","journal-title":"Am J Clin Nutr"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-090605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:34:00Z","timestamp":1765712040000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-090605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,26]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjopen-2024-090605"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-090605","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}